Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of CHANTIX® (Varenicline) Tablets Due to N-Nitroso Varenicline Content

Date: 07/19/2021

Product type: Drugs, Ingredient Level

Company Announcement Date: July 16, 2021
FDA Publish Date: July 19, 2021
Product Type: Drugs
Reason for Announcement: N-Nitroso Varenicline content above ADI level
Company Name: Pfizer
Brand Name: CHANTIX
Product Description: Smoking cessation treatment

US-FDA Link: